Patents by Inventor Toru Otake

Toru Otake has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220275456
    Abstract: To provide a differentiation marker gene set which, in the differentiation or classification of a breast cancer subtype, can perform differentiation or classification with high reproducibility by gene expression analysis. The above-described problem is solved by a differentiation marker gene set for differentiating or classifying a subtype of breast cancer. The differentiation marker gene set comprises a combination of genes obtained by selecting at least one gene from each gene group of at least one gene group selected from gene groups composed of groups a to o, the at least one gene group being selected in accordance with a desired subtype to be differentiated or classified.
    Type: Application
    Filed: July 16, 2020
    Publication date: September 1, 2022
    Inventors: Shinya WATANABE, Junichi IMAI, Emi ITO, Toru OTAKE, Noriko ABE, Kazunoshin TACHIBANA
  • Publication number: 20220267856
    Abstract: An object of the present invention is to provide a novel internal standard gene for gene expression analysis and to provide a gene expression analysis method using the internal standard gene. The present invention provides a gene expression analysis method for a test sample, comprising the steps of: (a) measuring an expression level of a desired gene; (b) measuring at least one internal standard gene selected from the group consisting of ABCF3, FBXW5, MLLT1, FAM234A, PITPNM1, WDR1, NDUFS7, and AP2A1; and (c) comparing the expression level of the desired gene with the expression level of the internal standard gene.
    Type: Application
    Filed: July 16, 2020
    Publication date: August 25, 2022
    Inventors: Shinya Watanabe, Junichi Imai, Emi Ito, Toru Otake, Noriko Abe, Kazunoshin Tachibana
  • Patent number: 5385891
    Abstract: Disclosed is a polysulfate of a .beta.-cyclodextrin in which at least one of 7 D-glucose units constituting the .beta.-cyclodextrin is a unit represented by the formula (I-a): ##STR1## wherein R.sup.1 is an alkyl group having 1 to 8 carbon atoms, a lower alkyl group having a substituent(s) or a lower alkenyl group, or a salt thereof, which has excellent antiretrovirus activity and is useful as an antiretrovirus agent.
    Type: Grant
    Filed: August 12, 1992
    Date of Patent: January 31, 1995
    Assignee: Tanabe Seiyaku Co., Ltd.
    Inventors: Tamon Moriya, Hironori Kurita, Toru Otake, Haruyo Mori, Motoko Morimoto
  • Patent number: 5250520
    Abstract: A polysulfate of a cyclodextrin in which at least one of 6 to 8 D-glucose units constituting the cyclodextrin has been replaced by a unit represented by Formula(1): ##STR1## wherein R is a group represented by the formula: ##STR2## where R.sup.1 to R.sup.7 are defined in the specification, which have an excellent antiretrovirus activity, particularly an excellent proliferation-inhibiting activity against HIV.
    Type: Grant
    Filed: March 13, 1991
    Date of Patent: October 5, 1993
    Assignee: Tanabe Seiyaku Co., Ltd.
    Inventors: Hironori Kurita, Tamon Moriya, Toru Otake, Haruyo Mori, Motoko Morimoto
  • Patent number: 5248675
    Abstract: A polysulfate of a cyclodextrin in which at least one of 6 to 8,D-glucose units constituting the cyclodextrin has been replaced by a unit represented by Formula (1): ##STR1## wherein R is a group represented by the formula: ##STR2## where R.sup.1 to R.sup.7 are defined in the specification, which have an excellent antiretrovirus activity, particularly an excellent proliferation-inhibiting activity against HIV.
    Type: Grant
    Filed: June 30, 1992
    Date of Patent: September 28, 1993
    Assignee: Tanabe Seiyaku Co., Ltd.
    Inventors: Hironori Kurita, Tamon Moriya, Toru Otake, Haruyo Mori, Motoko Morimoto